383 related articles for article (PubMed ID: 31755439)
1. Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.
Selzer EB; Welch RJ; Jabbour P; Leahey AM; Shields CL
Indian J Ophthalmol; 2019 Dec; 67(12):2005-2011. PubMed ID: 31755439
[TBL] [Abstract][Full Text] [Related]
2. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
4. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras.
Dalvin LA; Ancona-Lezama D; Lucio-Alvarez JA; Masoomian B; Jabbour P; Shields CL
Ophthalmology; 2018 Nov; 125(11):1803-1811. PubMed ID: 29921454
[TBL] [Abstract][Full Text] [Related]
7. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma.
Mirzayev I; Gündüz AK; Yavuz K; Şekkeli MZ; Özalp Ateş FS; Ünal E; Taçyıldız N
Eur J Ophthalmol; 2021 Sep; 31(5):2692-2698. PubMed ID: 32962409
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors.
Zheng Y; Froehler MT; Friedman DL; Daniels AB
Ophthalmol Retina; 2021 May; 5(5):479-485. PubMed ID: 32853834
[TBL] [Abstract][Full Text] [Related]
9. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment.
Munier FL; Mosimann P; Puccinelli F; Gaillard MC; Stathopoulos C; Houghton S; Bergin C; Beck-Popovic M
Br J Ophthalmol; 2017 Aug; 101(8):1086-1093. PubMed ID: 27927678
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial chemotherapy for retinoblastoma: Our first three-and-a-half years' experience in Malaysia.
Liu CC; Mohmood A; Hamzah N; Lau JH; Khaliddin N; Rahmat J
PLoS One; 2020; 15(5):e0232249. PubMed ID: 32357178
[TBL] [Abstract][Full Text] [Related]
11. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
Cancer Chemother Pharmacol; 2020 Apr; 85(4):723-730. PubMed ID: 32123960
[TBL] [Abstract][Full Text] [Related]
12. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
13. Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma.
Shields CL; Jorge R; Say EA; Magrath G; Alset A; Caywood E; Leahey AM; Jabbour P; Shields JA
Asia Pac J Ophthalmol (Phila); 2016; 5(2):97-103. PubMed ID: 26765038
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial chemotherapy for retinoblastoma: First Indian report.
Rishi P; Sharma T; Koundanya V; Bansal N; Saravanan M; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India.
Rishi P; Sharma T; Sharma M; Maitray A; Dhami A; Aggarwal V; Munusamy S; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2017 Apr; 65(4):311-315. PubMed ID: 28513496
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma.
Kumari N; Jain N; Saboo S; Parthasarathy R; Gupta V; Mahajan A; Das S
Indian J Ophthalmol; 2023 Feb; 71(2):436-443. PubMed ID: 36727336
[TBL] [Abstract][Full Text] [Related]
18. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
Shields CL; Bas Z; Tadepalli S; Dalvin LA; Rao R; Schwendeman R; Lally SE; Shields JA; Shah A; Leahey A
Br J Ophthalmol; 2020 Nov; 104(11):1548-1555. PubMed ID: 32051141
[TBL] [Abstract][Full Text] [Related]
19. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
20. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
